These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 21556717)

  • 1. Prophylactic eculizumab prior to kidney transplantation for atypical hemolytic uremic syndrome.
    Weitz M; Amon O; Bassler D; Koenigsrainer A; Nadalin S
    Pediatr Nephrol; 2011 Aug; 26(8):1325-9. PubMed ID: 21556717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tailored eculizumab therapy in the management of complement factor H-mediated atypical hemolytic uremic syndrome in an adult kidney transplant recipient: a case report.
    Xie L; Nester CM; Reed AI; Zhang Y; Smith RJ; Thomas CP
    Transplant Proc; 2012 Dec; 44(10):3037-40. PubMed ID: 23195022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of eculizumab and plasma exchange in successful combined liver-kidney transplantation in a case of atypical HUS associated with complement factor H mutation.
    Tran H; Chaudhuri A; Concepcion W; Grimm PC
    Pediatr Nephrol; 2014 Mar; 29(3):477-80. PubMed ID: 24221349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver transplantation for aHUS: still needed in the eculizumab era?
    Coppo R; Bonaudo R; Peruzzi RL; Amore A; Brunati A; Romagnoli R; Salizzoni M; Galbusera M; Gotti E; Daina E; Noris M; Remuzzi G
    Pediatr Nephrol; 2016 May; 31(5):759-68. PubMed ID: 26604087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Living Donor Kidney Transplantation in Atypical Hemolytic Uremic Syndrome: A Case Series.
    Duineveld C; Verhave JC; Berger SP; van de Kar NCAJ; Wetzels JFM
    Am J Kidney Dis; 2017 Dec; 70(6):770-777. PubMed ID: 28821363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atypical hemolytic uremic syndrome.
    Loirat C; Frémeaux-Bacchi V
    Orphanet J Rare Dis; 2011 Sep; 6():60. PubMed ID: 21902819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful 7-Year Eculizumab Treatment of Plasmapheresis-Resistant Recurrent Atypical Hemolytic-Uremic Syndrome due to Complement Factor H Hybrid Gene: A Case Report.
    Vondrák K; Seeman T
    Transplant Proc; 2018 Apr; 50(3):967-970. PubMed ID: 29661469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atypical hemolytic uremic syndrome recurrence after kidney transplantation.
    Matar D; Naqvi F; Racusen LC; Carter-Monroe N; Montgomery RA; Alachkar N
    Transplantation; 2014 Dec; 98(11):1205-12. PubMed ID: 24933457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylactic eculizumab for kidney transplantation in a child with atypical hemolytic uremic syndrome due to complement factor H mutation.
    Ranch D; Crowther B; Arar M; Assanasen C
    Pediatr Transplant; 2014 Sep; 18(6):E185-9. PubMed ID: 24931815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver-kidney transplantation to cure atypical HUS: still an option post-eculizumab?
    Saland J
    Pediatr Nephrol; 2014 Mar; 29(3):329-32. PubMed ID: 24362724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Ex Vivo Test of Complement Activation on Endothelium for Individualized Eculizumab Therapy in Hemolytic Uremic Syndrome.
    Galbusera M; Noris M; Gastoldi S; Bresin E; Mele C; Breno M; Cuccarolo P; Alberti M; Valoti E; Piras R; Donadelli R; Vivarelli M; Murer L; Pecoraro C; Ferrari E; Perna A; Benigni A; Portalupi V; Remuzzi G
    Am J Kidney Dis; 2019 Jul; 74(1):56-72. PubMed ID: 30851964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemolytic Uremic Syndrome and Kidney Transplantation: A Case Series and Review of the Literature.
    Milan Manani S; Virzì GM; Giuliani A; Clementi A; Brocca A; Dissegna D; Martino F; d''Amore ESG; Ronco C
    Nephron; 2017; 136(3):245-253. PubMed ID: 28419995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of eculizumab in renal transplantation.
    Barnett AN; Asgari E; Chowdhury P; Sacks SH; Dorling A; Mamode N
    Clin Transplant; 2013; 27(3):E216-29. PubMed ID: 23516966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maintenance of kidney function following treatment with eculizumab and discontinuation of plasma exchange after a third kidney transplant for atypical hemolytic uremic syndrome associated with a CFH mutation.
    Davin JC; Gracchi V; Bouts A; Groothoff J; Strain L; Goodship T
    Am J Kidney Dis; 2010 Apr; 55(4):708-11. PubMed ID: 19854549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal transplantation under prophylactic eculizumab in atypical hemolytic uremic syndrome with CFH/CFHR1 hybrid protein.
    Krid S; Roumenina LT; Beury D; Charbit M; Boyer O; Frémeaux-Bacchi V; Niaudet P
    Am J Transplant; 2012 Jul; 12(7):1938-44. PubMed ID: 22494769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Living kidney transplantation in adult patients with atypical haemolytic uraemic syndrome.
    Verhave JC; Westra D; van Hamersvelt HW; van Helden M; van de Kar NC; Wetzels JF
    Neth J Med; 2013 Sep; 71(7):342-7. PubMed ID: 24038559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and Safety of Eculizumab in Kidney Transplant Patients With Primary Atypical Hemolytic-Uremic Syndrome.
    González CC; López-Jiménez V; Vázquez-Sánchez T; Vázquez-Sánchez E; Cabello M; Hernández-Marrero D
    Transplant Proc; 2022; 54(1):25-26. PubMed ID: 34906374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-C5 as prophylactic therapy in atypical hemolytic uremic syndrome in living-related kidney transplantation.
    Pelicano MB; de Córdoba SR; Diekmann F; Saiz M; Herrero S; Oppenheimer F; Campistol JM
    Transplantation; 2013 Aug; 96(4):e26-9. PubMed ID: 23958887
    [No Abstract]   [Full Text] [Related]  

  • 19. Severe atypical HUS caused by CFH S1191L--case presentation and review of treatment options.
    De S; Waters AM; Segal AO; Trautmann A; Harvey EA; Licht C
    Pediatr Nephrol; 2010 Jan; 25(1):97-104. PubMed ID: 19856002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Atypical hemolytic-uremic syndrome related to abnormalities within the complement system].
    Frémeaux-Bacchi V; Fakhouri F; Roumenina L; Dragon-Durey MA; Loirat C
    Rev Med Interne; 2011 Apr; 32(4):232-40. PubMed ID: 21376430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.